On the 1st of April 2014, Eurofins MWG Operon and Eurofins Medigenomix have changed their brand names to Eurofins Genomics. With the combined power of their international network of Eurofins companies, they have established an outstanding team of experts and a broad range of technologies around five core business lines:
  • DNA & RNA Oligonucleotides
  • Custom DNA Sequencing
  • Next Generation Sequencing
  • Gene Synthesis & Molecular Biology
  • Genotyping & Gene Expression